Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Peter Mercado"'
Autor:
Yang Li, Denise B. Kandel, Kimberly A. Kempadoo, Luca Colnaghi, Eric R. Kandel, Philippe A. Melas, Royce Zhou, Edmund A. Griffin, Mei-Chen Hu, Peter Mercado, Stacy Stephenson, Kathleen M. Taylor
Publikováno v:
Science Advances
Prior alcohol use increases vulnerability to cocaine addiction by promoting degradation of HDAC4 and HDAC5.
Addiction to cocaine is commonly preceded by experiences with legal or decriminalized drugs, such as alcohol, nicotine, and marijuana. Th
Addiction to cocaine is commonly preceded by experiences with legal or decriminalized drugs, such as alcohol, nicotine, and marijuana. Th
Inducible expression of TGFβ, Snail and Zeb1 recapitulates EMT in vitro and in vivo in a NSCLC model
Autor:
Julie L.C. Kan, Stuart Thomson, David Epstein, Joseph S. Krueger, Maryland Rosenfeld-Franklin, Regina Sennello, John D. Haley, G. David Young, Peter Mercado, Jonathan A. Pachter, Krista Carey, Matthew O'Connor, Robert A. Wild, Stacia Silva, Gretchen M. Argast, Iain J. Mulford, Isabela Sujka-Kwok
Publikováno v:
Clinical & Experimental Metastasis. 28:593-614
The progression of cancer from non-metastatic to metastatic is the critical transition in the course of the disease. The epithelial to mesenchymal transition (EMT) is a mechanism by which tumor cells acquire characteristics that improve metastatic ef
Autor:
Filippo Petti, Jonathan F. Bean, Stuart Thomson, David Epstein, Melissa Monaghan, John D. Haley, Gretchen M. Argast, Peter Mercado, Sean L. Seymour, Izabela Sujka-Kwok
Publikováno v:
Clinical & Experimental Metastasis
Abtract Epithelial–mesenchymal transition (EMT) is an important contributor to the invasion and metastasis of epithelial-derived cancers. While considerable effort has focused in the regulators involved in the transition process, we have focused on
Autor:
Matthew O'Connor, Gretchen M. Argast, Iain J. Mulford, David M. Keane, Julie L.C. Kan, Salam Shaaban, Jonathan A. Pachter, Peter Mercado, David Epstein
Publikováno v:
Cells Tissues Organs. 193:114-132
Epithelial to mesenchymal transition (EMT) plays a dual role in tumor progression. It enhances metastasis of tumor cells by increasing invasive capacity and promoting survival, and it decreases tumor cell sensitivity to epithelial cell-targeting agen
Autor:
Frank, Richardson, G David, Young, Regina, Sennello, Julie, Wolf, Gretchen M, Argast, Peter, Mercado, Angela, Davies, David M, Epstein, Bret, Wacker
Publikováno v:
Anticancer research. 32(2)
E-Cadherin and vimentin protein expression was assessed in late stage non-small cell lung cancer tumors from the placebo controlled clinical trial, NCIC-CTG BR.21, to determine if these markers had the potential to predict outcome of erlotinib therap
Autor:
S. Rhiannon Jenkinson, Guangping Sun, Rémy Bosselut, Magdalini Kypriotou, Lionel Feigenbaum, Xiaolong Liu, Peter Mercado, Philippe Galéra
Publikováno v:
Nature immunology. 6(4)
The genetic programs directing CD4 or CD8 T cell differentiation in the thymus remain poorly understood. While analyzing gene expression during intrathymic T cell selection, we found that Zfp67, encoding the zinc finger transcription factor cKrox, wa
Autor:
Jan Bauer, Peter Mercado, Katerina Akassoglou, Ryan A. Adams, Hans Lassmann, Sidney Strickland, Vivian Tseveleki, Lesley Probert
Publikováno v:
Akassoglou, K; Adams, R A; Bauer, J; Mercado, P; Tseveleki, V; Lassmann, H; et al.(2004). Fibrin depletion decreases inflammation and delays the onset of demyelination in a tumor necrosis factor transgenic mouse model for multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 101(17), 6698-6703. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/34d0d512
In multiple sclerosis, in which brain tissue becomes permeable to blood proteins, extravascular fibrin deposition correlates with sites of inflammatory demyelination and axonal damage. To examine the role of fibrin in neuroinflammatory demyelination,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d220619e148d1ce103aa076f17ebd078
http://www.escholarship.org/uc/item/34d0d512
http://www.escholarship.org/uc/item/34d0d512
Autor:
Peter Mercado, John D. Haley, Andrew Chau, Erica Ullman, Jonathan F. Bean, Elizabeth Buck, Stuart Thomson, David Epstein, Mark Miglarese
Publikováno v:
Clinical Cancer Research. 18:B56-B56
Resistance to targeted therapies is emerging as a major theme in cancer research. As more therapies become used routinely in the clinic it is apparent that although significant responses are observed the majority of patients progress while on therapy
Autor:
Kenneth K. Iwata, Andrew Chau, David Epstein, Eric N. Brown, Stuart Thomson, Peter Mercado, Mark Miglarese, Maryland Rosenfeld-Franklin, Gretchen M. Argast
Publikováno v:
Cancer Research. 71:3370-3370
The EGFR kinase inhibitor erlotinib is approved as a maintenance therapy in 1st line NSCLC as well as for treatment of 2nd/3rd line NSCLC and in combination with Gemcitabine for pancreatic cancer. It has been observed that the most pronounced respons
Autor:
Stuart Thomson, Jonathan A. Pachter, Gretchen M. Argast, Peter Mercado, Iain J. Mulford, Matthew O'Connor, David Epstein, Julie L.C. Kan
Publikováno v:
Cancer Research. 70:1463-1463
The phenotypic changes associated with epithelial to mesenchymal transition (EMT) give tumor cells at least two attributes that increase metastatic efficiency. First, mesenchymal cells have lost cell-cell contacts and are more invasive and can theref